Ms Hagen has more than 25 years of experience from the pharmaceutical industry and extensive knowledge of radiopharmacy. Prior to joining Nordic Nanovector she was head of QA at Oslo University Hospital (Norsk medisinsk syklotronsenter AS) and responsible for building facilities and QMS for GMP manufacturing of positron emission radiopharmaceuticals (PET). The organisation achieved manufacturing licence under her management and she was qualified person (QP) for the manufacturing activities. Previously, Ms Hagen worked at Algeta ASA as QC manager and was also a part of the team compiling the quality dossier for IND application. She has also experience with cell-based drug delivery systems for, among others, anticancer therapeutics from Pronova Biomedical AS. Ms Hagen is a trained chemist and earned a cand.scient in radiochemistry from the University of Oslo. Ms Hagen joined Nordic Nanovector in June 2012.